4/15 (26%) of patients at Sheba 2.0 experienced elevated Troponin levels.
Even a slight increase in the troponin level will often mean there has been some damage to the heart.
24-27% of Clofarabine patients experience cardiotoxicity (LV dysfunction) - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352330/
If you were to sit in a quiet room and apply logic and deep thinking to the above; one might conclude that the cardiotoxic effect of Clofarabine was experienced by 26% of patients at Sheba 2.0. Fortunately, Clofarabine was also dosed with a drug that, albeit preclinically, has been shown to protect heart cells from damage by multiple anticancer agents...
Cardioprotection thread, page-871
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.54 |
Change
-0.040(2.54%) |
Mkt cap ! $260.8M | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.59 | $1.51 | $174.6K | 113.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1010 | $1.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 141 | 1 |
View Market Depth
| Last trade - 15.59pm 11/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |